Bath salts (drug) (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bath salts (drug)" in English language version.

refsWebsite

Global rank English rank

22nih.gov

4^th place

19doi.org

2^nd place

10web.archive.org

1^st place

7worldcat.org

5^th place

4bbc.co.uk

8^th place

10^th place

2justice.gov

918^th place

556^th place

2semanticscholar.org

11^th place

8^th place

2theguardian.com

12^th place

11^th place

2vice.com

175^th place

137^th place

1cbc.ca

115^th place

82^nd place

1newsweek.com

269^th place

201^st place

1europa.eu

68^th place

117^th place

1erowid.org

3,887^th place

3,197^th place

1harvard.edu

18^th place

17^th place

1biomedicalpublications.com

low place

1newsday.com

853^rd place

505^th place

1legislation.gov.uk

809^th place

536^th place

1nationalarchives.gov.uk

744^th place

547^th place

1drugs.homeoffice.gov.uk

low place

1time.com

61^st place

54^th place

1ncsl.org

6,017^th place

3,563^rd place

1nytimes.com

7^th place

1al.com

963^rd place

540^th place

1cnn.com

28^th place

26^th place

1telegraph.co.uk

30^th place

24^th place

1stokesentinel.co.uk

5,309^th place

2,904^th place

1sagepub.com

731^st place

638^th place

1theconversation.com

928^th place

651^st place

1bostonglobe.com

553^rd place

334^th place

1sun-sentinel.com

609^th place

366^th place

1go.com

48^th place

39^th place

1aapcc.org

low place

aapcc.org

"Bath Salts". American Association of Poison Control Centers. Archived from the original on 19 January 2017. Retrieved 18 January 2017. In 2012, poison centers took 2,697 calls about exposures to bath salts with the number reducing to 998 in 2013. In 2014, there were 587 exposure calls with the number reducing to 522 in 2015.

al.com

blog.al.com

Cumbow, Victoria (6 February 2011). "Synthetic form of cocaine and methamphetamine being packaged as bath salts". The Huntsville Times. Retrieved 10 February 2011.

bbc.co.uk

news.bbc.co.uk

Reed, Jim (13 January 2010). "Clubbers are 'turning to new legal high mephedrone'". BBC News. Retrieved 4 July 2010.
"BBC – Democracy Live – MPs move to ban mephedrone". BBC News. 7 April 2010. Retrieved 28 December 2013.
"Police warning over 'bubble' drug". BBC News. 20 November 2009. Retrieved 28 December 2013.

bbc.co.uk

"NRG-1 'legal high' drug is banned". BBC News. 12 July 2010. Retrieved 28 December 2013.

biomedicalpublications.com

Baselt, R. (2017). Disposition of Toxic Drugs and Chemicals in Man (PDF) (11th ed.). Seal Beach, CA: Biomedical Publications. pp. 1280–1282. Archived from the original (PDF) on 25 April 2012. Retrieved 29 June 2012.

bostonglobe.com

Laboy, Suzette (27 June 2012). "Tests find only marijuana in face-chewer's system". The Boston Globe. Associated Press.

cbc.ca

Black, Matthew (25 June 2012). "What are 'bath salts'? A look at Canada's newest illegal drug". CBC News. Canadian Broadcasting Corporation. Retrieved 28 December 2013.

cnn.com

news.blogs.cnn.com

"Reports: Miami 'zombie' attacker may have been using 'bath salts'". CNN. 29 May 2012. Archived from the original on 25 March 2021. Retrieved 28 December 2013.

doi.org

Gray, Bobbe Ann; Holland, Cindra (June 2014). "Implications of Psychoactive 'Bath Salts' Use During Pregnancy". Nursing for Women's Health. 18 (3): 220–30. doi:10.1111/1751-486X.12123. PMID 24939199.
Ross, Edward A.; Watson, Mary; Goldberger, Bruce (8 September 2011). ""Bath Salts" Intoxication". New England Journal of Medicine. 365 (10): 967–8. doi:10.1056/NEJMc1107097. PMID 21899474.
Spiller HA, Ryan ML, Weston RG, Jansen J (2011). "Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States". Clinical Toxicology. 49 (6): 499–505. doi:10.3109/15563650.2011.590812. PMID 21824061. S2CID 33364692.
Coppola M, Mondola R (2012). "Synthetic cathinones: Chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food"". Toxicology Letters. 211 (2): 144–149. doi:10.1016/j.toxlet.2012.03.009. PMID 22459606.
Prosser JM, Nelson LS (2011). "The Toxicology of Bath Salts: A Review of Synthetic Cathinones". Journal of Medical Toxicology. 8 (1): 33–42. doi:10.1007/s13181-011-0193-z. PMC 3550219. PMID 22108839.
Ross, EA; Watson, M; Goldberger, B (8 September 2011). ""Bath Salts" Intoxication". The New England Journal of Medicine. 365 (10): 967–968. doi:10.1056/NEJMc1107097. PMID 21899474.
Kehr, J.; Ichinose, F.; Yoshitake, S.; Goiny, M.; Sievertsson, T.; Nyberg, F.; Yoshitake, T. (April 2011). "Mephedrone, compared to MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and serotonin levels in nucleus accumbens of awake rats". British Journal of Pharmacology. 164 (8): 1949–58. doi:10.1111/j.1476-5381.2011.01499.x. PMC 3246659. PMID 21615721.
Ciudad-Roberts, Andrés; Camarasa, Jorge; Ciudad, Carlos J.; Pubill, David; Escubedo, Elena (2015). "Alcohol enhances the psychostimulant and conditioning effects of mephedrone in adolescent mice; postulation of unique roles of D receptors and BDNF in place preference acquisition". British Journal of Pharmacology. 172 (20): 4970–4984. doi:10.1111/bph.13266. PMC 4621996. PMID 26228024.
Penders, Thomas M.; Gestring, Richard (1 September 2011). "Hallucinatory delirium following use of MDPV: 'Bath Salts'". General Hospital Psychiatry. 33 (5): 525–526. doi:10.1016/j.genhosppsych.2011.05.014. ISSN 0163-8343. PMID 21762997.
Sivagnanam G. (3 February 2012). "News and Views: 'Drug abuse' of a different 'wave' length". Journal of Pharmacology and Pharmacotherapeutics. 3 (1): 85–86. doi:10.4103/0976-500x.92493 (inactive 2 November 2024).{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link) (contains additional text)
Mugele, Josh; Nañagas, Kristine A.; Tormoehlen, Laura M. (July 2012). "Serotonin Syndrome Associated with MDPV Use: A Case Report". Annals of Emergency Medicine. 60 (1): 100–102. doi:10.1016/j.annemergmed.2011.11.033. ISSN 0196-0644. PMID 22237165.
Aarde, S. M.; Huang, P. K.; Dickerson, T. J.; Taffe, M. A. (1 June 2015). "Binge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in rats". Psychopharmacology. 232 (11): 1867–1877. doi:10.1007/s00213-014-3819-4. ISSN 1432-2072. PMC 4426253. PMID 25424056.
Beck, Olof; Bäckberg, Matilda; Signell, Patrick; Helander, Anders (2017). "Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats". Clinical Toxicology. 56 (4): 256–263. doi:10.1080/15563650.2017.1370097. PMID 28895757.
Winder, G. S.; Stern, N.; Hosanagar, A. (March 2012). "Are "Bath Salts" the next generation of stimulant abuse?". J Subst Abuse Treat. 44 (1): 42–45. doi:10.1016/j.jsat.2012.02.003. PMID 22445773.
Rust KY, Baumgartner MR, Dally AM, Kraemer T (2012). "Prevalence of new psychoactive substances: A retrospective study in hair". Drug Testing and Analysis. 4 (6): 402–408. doi:10.1002/dta.1338. PMID 22522922.
Brandt, SD; Sumnall, HR; Measham, F; Cole, J (July 2010). "Second generation mephedrone: The confusing case of NRG-1". British Medical Journal. 341: c3564. doi:10.1136/bmj.c3564. PMID 20605894. S2CID 20354123.
Baumann, Michael H.; Bukhari, Mohammad O.; Lehner, Kurt R.; Anizan, Sebastien; Rice, Kenner C.; Concheiro, Marta; Huestis, Marilyn A. (2017). "Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs". Current Topics in Behavioral Neurosciences. 32: 93–117. doi:10.1007/7854_2016_53. ISBN 978-3-319-52442-9. ISSN 1866-3370. PMC 5392131. PMID 27830575.
Swalve, Natashia; Defoster, Ruth (2017). How Broadcast Media Discuss New Drug "Epidemics": Integrating Neuroscience With Communication Studies Through Textual Framing - SAGE Research Methods. doi:10.4135/9781526409508. ISBN 9781526409508. Retrieved 8 February 2019. {{cite book}}: |website= ignored (help)
McElrath, K; O'Neill, C (March 2011). "Experiences with mephedrone pre- and post-legislative controls: perceptions of safety and sources of supply". The International Journal on Drug Policy. 22 (2): 120–7. doi:10.1016/j.drugpo.2010.11.001. PMID 21242082.

drugs.homeoffice.gov.uk

"Consideration of the Cathinones" (PDF). Advisory Council on the Misuse of Drugs. 31 March 2010. p. 25. Archived from the original (PDF) on 2 April 2010. Retrieved 1 April 2010.

erowid.org

"Products - Bath Salts, Plant Food, etc (also Bath Salts; Plant Food; Fertilizer) | Erowid experience vaults". erowid.org. Retrieved 8 August 2020.

europa.eu

emcdda.europa.eu

"Europol–EMCDDA Joint Report on a new psychoactive substance: 4-methylmethcathinone (mephedrone)" (PDF). European Monitoring Centre for Drugs and Drug Addiction. 27 May 2010. Archived from the original (PDF) on 8 April 2011.

go.com

abcnews.go.com

Dolak, Kevin (5 June 2012). "'Bath Salts': Use of Dangerous Drug Increasing Across U.S." ABC News: Good Morning America. Retrieved 28 December 2013. ( Page will play audio when loaded)

harvard.edu

health.harvard.edu

Miller, Michael C. (September 2011). "Ask the Doctor: Bath salts—a new way to get high?". Harvard Mental Health Letter. Archived from the original on 17 January 2021. Retrieved 18 December 2013.
Q. I heard a news story about people using bath salts to get high. How is that possible? My husband and I have two teenagers. Should we talk with them about this?

A. The "bath salts" you've heard about have nothing to do with the type that people add to water and use while soaking in a tub. These newer bath salts are designer drugs that circumvent the laws governing controlled or illegal substances, but can be used to get high.

The active chemicals in these salts—mephedrone, pyrovalerone, or methylenedioxypyrovalerone (MDPV)—all have stimulant properties. They are ... (contains additional text)

justice.gov

"DEA: Chemicals Used in "Bath Salts" Now Under Federal Control and Regulation". Archived from the original on 25 April 2014. Retrieved 28 December 2013.
"Situation Report. Synthetic Cathinones (Bath Salts): An Emerging Domestic Threat" (PDF). United States Department of Justice: National Drug Intelligence Center. Retrieved 1 June 2013.

legislation.gov.uk

"The Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2010 No. 1144". Office of Public Sector Information. 16 April 2010. Archived from the original on 5 January 2011.

nationalarchives.gov.uk

webarchive.nationalarchives.gov.uk

"Consideration of the Cathinones" (PDF). Advisory Council on the Misuse of Drugs. 31 March 2010. p. 25. Archived from the original (PDF) on 2 April 2010. Retrieved 1 April 2010.

ncsl.org

"Synthetic Drug Threats". National Conference of State Legislatures. 28 November 2012. Retrieved 28 December 2013.

newsday.com

"'Bath salts,' synthetic drugs targeted in Schneiderman lawsuits". Long Island Newsday. 10 July 2012. Archived from the original on 28 December 2013. Retrieved 18 December 2013.

newsweek.com

"Monkey dust "epidemic" causing drug users to experience violent hallucinations". Newsweek. 10 August 2018. Retrieved 17 August 2018.

nih.gov

pubmed.ncbi.nlm.nih.gov

Gray, Bobbe Ann; Holland, Cindra (June 2014). "Implications of Psychoactive 'Bath Salts' Use During Pregnancy". Nursing for Women's Health. 18 (3): 220–30. doi:10.1111/1751-486X.12123. PMID 24939199.
Ross, Edward A.; Watson, Mary; Goldberger, Bruce (8 September 2011). ""Bath Salts" Intoxication". New England Journal of Medicine. 365 (10): 967–8. doi:10.1056/NEJMc1107097. PMID 21899474.
Spiller HA, Ryan ML, Weston RG, Jansen J (2011). "Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States". Clinical Toxicology. 49 (6): 499–505. doi:10.3109/15563650.2011.590812. PMID 21824061. S2CID 33364692.
Coppola M, Mondola R (2012). "Synthetic cathinones: Chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food"". Toxicology Letters. 211 (2): 144–149. doi:10.1016/j.toxlet.2012.03.009. PMID 22459606.
Prosser JM, Nelson LS (2011). "The Toxicology of Bath Salts: A Review of Synthetic Cathinones". Journal of Medical Toxicology. 8 (1): 33–42. doi:10.1007/s13181-011-0193-z. PMC 3550219. PMID 22108839.
Ross, EA; Watson, M; Goldberger, B (8 September 2011). ""Bath Salts" Intoxication". The New England Journal of Medicine. 365 (10): 967–968. doi:10.1056/NEJMc1107097. PMID 21899474.
Kehr, J.; Ichinose, F.; Yoshitake, S.; Goiny, M.; Sievertsson, T.; Nyberg, F.; Yoshitake, T. (April 2011). "Mephedrone, compared to MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and serotonin levels in nucleus accumbens of awake rats". British Journal of Pharmacology. 164 (8): 1949–58. doi:10.1111/j.1476-5381.2011.01499.x. PMC 3246659. PMID 21615721.
Ciudad-Roberts, Andrés; Camarasa, Jorge; Ciudad, Carlos J.; Pubill, David; Escubedo, Elena (2015). "Alcohol enhances the psychostimulant and conditioning effects of mephedrone in adolescent mice; postulation of unique roles of D receptors and BDNF in place preference acquisition". British Journal of Pharmacology. 172 (20): 4970–4984. doi:10.1111/bph.13266. PMC 4621996. PMID 26228024.
Penders, Thomas M.; Gestring, Richard (1 September 2011). "Hallucinatory delirium following use of MDPV: 'Bath Salts'". General Hospital Psychiatry. 33 (5): 525–526. doi:10.1016/j.genhosppsych.2011.05.014. ISSN 0163-8343. PMID 21762997.
Mugele, Josh; Nañagas, Kristine A.; Tormoehlen, Laura M. (July 2012). "Serotonin Syndrome Associated with MDPV Use: A Case Report". Annals of Emergency Medicine. 60 (1): 100–102. doi:10.1016/j.annemergmed.2011.11.033. ISSN 0196-0644. PMID 22237165.
Aarde, S. M.; Huang, P. K.; Dickerson, T. J.; Taffe, M. A. (1 June 2015). "Binge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in rats". Psychopharmacology. 232 (11): 1867–1877. doi:10.1007/s00213-014-3819-4. ISSN 1432-2072. PMC 4426253. PMID 25424056.
Beck, Olof; Bäckberg, Matilda; Signell, Patrick; Helander, Anders (2017). "Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats". Clinical Toxicology. 56 (4): 256–263. doi:10.1080/15563650.2017.1370097. PMID 28895757.
Winder, G. S.; Stern, N.; Hosanagar, A. (March 2012). "Are "Bath Salts" the next generation of stimulant abuse?". J Subst Abuse Treat. 44 (1): 42–45. doi:10.1016/j.jsat.2012.02.003. PMID 22445773.
Rust KY, Baumgartner MR, Dally AM, Kraemer T (2012). "Prevalence of new psychoactive substances: A retrospective study in hair". Drug Testing and Analysis. 4 (6): 402–408. doi:10.1002/dta.1338. PMID 22522922.
Brandt, SD; Sumnall, HR; Measham, F; Cole, J (July 2010). "Second generation mephedrone: The confusing case of NRG-1". British Medical Journal. 341: c3564. doi:10.1136/bmj.c3564. PMID 20605894. S2CID 20354123.
Baumann, Michael H.; Bukhari, Mohammad O.; Lehner, Kurt R.; Anizan, Sebastien; Rice, Kenner C.; Concheiro, Marta; Huestis, Marilyn A. (2017). "Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs". Current Topics in Behavioral Neurosciences. 32: 93–117. doi:10.1007/7854_2016_53. ISBN 978-3-319-52442-9. ISSN 1866-3370. PMC 5392131. PMID 27830575.
McElrath, K; O'Neill, C (March 2011). "Experiences with mephedrone pre- and post-legislative controls: perceptions of safety and sources of supply". The International Journal on Drug Policy. 22 (2): 120–7. doi:10.1016/j.drugpo.2010.11.001. PMID 21242082.

ncbi.nlm.nih.gov

Prosser JM, Nelson LS (2011). "The Toxicology of Bath Salts: A Review of Synthetic Cathinones". Journal of Medical Toxicology. 8 (1): 33–42. doi:10.1007/s13181-011-0193-z. PMC 3550219. PMID 22108839.
Kehr, J.; Ichinose, F.; Yoshitake, S.; Goiny, M.; Sievertsson, T.; Nyberg, F.; Yoshitake, T. (April 2011). "Mephedrone, compared to MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and serotonin levels in nucleus accumbens of awake rats". British Journal of Pharmacology. 164 (8): 1949–58. doi:10.1111/j.1476-5381.2011.01499.x. PMC 3246659. PMID 21615721.
Ciudad-Roberts, Andrés; Camarasa, Jorge; Ciudad, Carlos J.; Pubill, David; Escubedo, Elena (2015). "Alcohol enhances the psychostimulant and conditioning effects of mephedrone in adolescent mice; postulation of unique roles of D receptors and BDNF in place preference acquisition". British Journal of Pharmacology. 172 (20): 4970–4984. doi:10.1111/bph.13266. PMC 4621996. PMID 26228024.
Aarde, S. M.; Huang, P. K.; Dickerson, T. J.; Taffe, M. A. (1 June 2015). "Binge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in rats". Psychopharmacology. 232 (11): 1867–1877. doi:10.1007/s00213-014-3819-4. ISSN 1432-2072. PMC 4426253. PMID 25424056.
Baumann, Michael H.; Bukhari, Mohammad O.; Lehner, Kurt R.; Anizan, Sebastien; Rice, Kenner C.; Concheiro, Marta; Huestis, Marilyn A. (2017). "Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs". Current Topics in Behavioral Neurosciences. 32: 93–117. doi:10.1007/7854_2016_53. ISBN 978-3-319-52442-9. ISSN 1866-3370. PMC 5392131. PMID 27830575.

nytimes.com

Goodnough, Abby; Zezima, Katie (16 July 2011). "An Alarming New Stimulant, Legal in Many States". The New York Times. Retrieved 15 January 2012.

sagepub.com

methods.sagepub.com

Swalve, Natashia; Defoster, Ruth (2017). How Broadcast Media Discuss New Drug "Epidemics": Integrating Neuroscience With Communication Studies Through Textual Framing - SAGE Research Methods. doi:10.4135/9781526409508. ISBN 9781526409508. Retrieved 8 February 2019. {{cite book}}: |website= ignored (help)

semanticscholar.org

api.semanticscholar.org

Spiller HA, Ryan ML, Weston RG, Jansen J (2011). "Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States". Clinical Toxicology. 49 (6): 499–505. doi:10.3109/15563650.2011.590812. PMID 21824061. S2CID 33364692.
Brandt, SD; Sumnall, HR; Measham, F; Cole, J (July 2010). "Second generation mephedrone: The confusing case of NRG-1". British Medical Journal. 341: c3564. doi:10.1136/bmj.c3564. PMID 20605894. S2CID 20354123.

stokesentinel.co.uk

Davies, Ruby (20 November 2018). "Monkey dust couple's warning before setting their house on fire". stokesentinel. Retrieved 8 February 2019.

sun-sentinel.com

articles.sun-sentinel.com

"Causeway Cannibal: Toxicology reports say Rudy Eugene was not on bath salts, but not everyone believes them". Sun Sentinel. Fort Lauderdale, Florida. 20 August 2012. Archived from the original on 20 August 2012. Retrieved 25 January 2022.

telegraph.co.uk

Johnson, Jamie (15 August 2018). "Monkey dust warning as police say increasingly popular drug is leading to people jumping off buildings". The Telegraph. ISSN 0307-1235. Retrieved 8 February 2019.

theconversation.com

Page, Sarah (6 September 2018). "Monkey Dust mayhem: the English city reportedly at the centre of a drug-fuelled 'epidemic'". The Conversation. Retrieved 8 February 2019.

theguardian.com

Marsh, Sarah (17 August 2018). "Surge in monkey dust drug use linked to social media, police say". The Guardian. ISSN 0261-3077. Retrieved 8 February 2019.
Boseley, Sarah (4 July 2014). "Psychonauts explore unknown world of legal highs—with themselves as lab rats". The Guardian. ISSN 0261-3077. Retrieved 8 February 2019.

time.com

newsfeed.time.com

Haggin, Patience (10 July 2012). "Obama Signs Federal Ban on 'Bath Salt' Drugs". Time. Newsfeed. Retrieved 28 December 2013.

vice.com

Daly, Max; Clifton, Jamie (16 August 2018). "The Truth About 'Monkey Dust', UK Media's Latest Drug Obsession". Vice. Retrieved 8 February 2019.
Morris, H. (5 April 2010). "Hamilton's Pharmacopeia. Mephedrone: the phantom menace". Vice Magazine. Archived from the original on 30 October 2011.

web.archive.org

"DEA: Chemicals Used in "Bath Salts" Now Under Federal Control and Regulation". Archived from the original on 25 April 2014. Retrieved 28 December 2013.
"Europol–EMCDDA Joint Report on a new psychoactive substance: 4-methylmethcathinone (mephedrone)" (PDF). European Monitoring Centre for Drugs and Drug Addiction. 27 May 2010. Archived from the original (PDF) on 8 April 2011.
Miller, Michael C. (September 2011). "Ask the Doctor: Bath salts—a new way to get high?". Harvard Mental Health Letter. Archived from the original on 17 January 2021. Retrieved 18 December 2013.
Q. I heard a news story about people using bath salts to get high. How is that possible? My husband and I have two teenagers. Should we talk with them about this?

A. The "bath salts" you've heard about have nothing to do with the type that people add to water and use while soaking in a tub. These newer bath salts are designer drugs that circumvent the laws governing controlled or illegal substances, but can be used to get high.

The active chemicals in these salts—mephedrone, pyrovalerone, or methylenedioxypyrovalerone (MDPV)—all have stimulant properties. They are ... (contains additional text)
Baselt, R. (2017). Disposition of Toxic Drugs and Chemicals in Man (PDF) (11th ed.). Seal Beach, CA: Biomedical Publications. pp. 1280–1282. Archived from the original (PDF) on 25 April 2012. Retrieved 29 June 2012.
"'Bath salts,' synthetic drugs targeted in Schneiderman lawsuits". Long Island Newsday. 10 July 2012. Archived from the original on 28 December 2013. Retrieved 18 December 2013.
"The Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2010 No. 1144". Office of Public Sector Information. 16 April 2010. Archived from the original on 5 January 2011.
"Reports: Miami 'zombie' attacker may have been using 'bath salts'". CNN. 29 May 2012. Archived from the original on 25 March 2021. Retrieved 28 December 2013.
"Causeway Cannibal: Toxicology reports say Rudy Eugene was not on bath salts, but not everyone believes them". Sun Sentinel. Fort Lauderdale, Florida. 20 August 2012. Archived from the original on 20 August 2012. Retrieved 25 January 2022.
Morris, H. (5 April 2010). "Hamilton's Pharmacopeia. Mephedrone: the phantom menace". Vice Magazine. Archived from the original on 30 October 2011.
"Bath Salts". American Association of Poison Control Centers. Archived from the original on 19 January 2017. Retrieved 18 January 2017. In 2012, poison centers took 2,697 calls about exposures to bath salts with the number reducing to 998 in 2013. In 2014, there were 587 exposure calls with the number reducing to 522 in 2015.

worldcat.org

search.worldcat.org

Penders, Thomas M.; Gestring, Richard (1 September 2011). "Hallucinatory delirium following use of MDPV: 'Bath Salts'". General Hospital Psychiatry. 33 (5): 525–526. doi:10.1016/j.genhosppsych.2011.05.014. ISSN 0163-8343. PMID 21762997.
Mugele, Josh; Nañagas, Kristine A.; Tormoehlen, Laura M. (July 2012). "Serotonin Syndrome Associated with MDPV Use: A Case Report". Annals of Emergency Medicine. 60 (1): 100–102. doi:10.1016/j.annemergmed.2011.11.033. ISSN 0196-0644. PMID 22237165.
Aarde, S. M.; Huang, P. K.; Dickerson, T. J.; Taffe, M. A. (1 June 2015). "Binge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in rats". Psychopharmacology. 232 (11): 1867–1877. doi:10.1007/s00213-014-3819-4. ISSN 1432-2072. PMC 4426253. PMID 25424056.
Marsh, Sarah (17 August 2018). "Surge in monkey dust drug use linked to social media, police say". The Guardian. ISSN 0261-3077. Retrieved 8 February 2019.
Johnson, Jamie (15 August 2018). "Monkey dust warning as police say increasingly popular drug is leading to people jumping off buildings". The Telegraph. ISSN 0307-1235. Retrieved 8 February 2019.
Baumann, Michael H.; Bukhari, Mohammad O.; Lehner, Kurt R.; Anizan, Sebastien; Rice, Kenner C.; Concheiro, Marta; Huestis, Marilyn A. (2017). "Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs". Current Topics in Behavioral Neurosciences. 32: 93–117. doi:10.1007/7854_2016_53. ISBN 978-3-319-52442-9. ISSN 1866-3370. PMC 5392131. PMID 27830575.
Boseley, Sarah (4 July 2014). "Psychonauts explore unknown world of legal highs—with themselves as lab rats". The Guardian. ISSN 0261-3077. Retrieved 8 February 2019.